Dr. Morganna Vance, D.O., FACP

Dr. Morganna Vance is a board-certified medical oncologist who now serves as Executive Director and Global Development Lead for the skin cancer and sarcoma franchises at Iovance Biotherapeutics, a role she has held since November 2025. In this position, she works across organizational functions to shape strategy, assess risk, and guide cross-functional teams in advancing melanoma therapies, drawing on her scientific background to build relationships with cancer centers worldwide and expand patient access to care. Before joining Iovance, she held senior director positions at Exelixis and Gilead Sciences, where she contributed to leadership efforts behind pivotal Phase 3 trials in metastatic urothelial and renal cell carcinoma, and she also served in senior medical roles at Artiva Biotherapeutics and Novocure.

A clinician-turned-industry leader, Dr. Vance practiced as an oncologist for a decade, including time as an Assistant Clinical Professor at City of Hope, before moving into pharmaceuticals roughly seven years ago to work on clinical trials capable of reaching far larger patient populations. Her academic path began with a Bachelor of Science in Biology and Chemistry from St. Mary's University, followed by a Doctor of Medicine from the Lake Erie College of Osteopathic Medicine. She completed her internal medicine residency and chief residency at the University of Florida, then pursued a hematology/oncology fellowship at Moffitt Cancer Center and the University of South Florida, concentrating on the tumor microenvironment and immunotherapy approaches to melanoma and non-small cell lung cancer. She is board-certified in both internal medicine and medical oncology and holds fellowship status with the American College of Physicians.

Beyond her clinical and industry work, Dr. Vance is an active voice in health policy, having completed a formal health policy fellowship and served a three-year term with the ASCO Government Relations Committee. She holds memberships with the Healthcare Businesswomen's Association, SWOG's Melanoma Committee Working Group, and the Society for Melanoma Research's Melanoma Prevention Working Group, and she was honored with the Melanoma Research Foundation's Humanitarian Award in 2018. A dedicated mentor to women in pharma, she credits a formative fellowship mentorship with shaping her own career and remains passionate about guiding the next generation of scientific leaders. Outside of work, she is an avid long-distance cyclist and has participated in international medical volunteering efforts, including work in Kenya.